| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.030 | 54.694 | 31.027 | 12.597 | 24.076 | 17.226 | 26.889 | 21.796 | 23.253 | 32.479 |
| Total Income - EUR | 6.030 | 55.619 | 32.116 | 12.696 | 24.076 | 17.226 | 26.889 | 21.796 | 23.253 | 32.479 |
| Total Expenses - EUR | 4.282 | 33.830 | 25.811 | 11.911 | 22.166 | 16.729 | 21.621 | 21.559 | 22.228 | 32.755 |
| Gross Profit/Loss - EUR | 1.748 | 21.789 | 6.305 | 785 | 1.910 | 498 | 5.268 | 237 | 1.024 | -276 |
| Net Profit/Loss - EUR | 1.567 | 21.242 | 5.994 | 659 | 1.658 | 325 | 4.999 | 19 | 792 | -601 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Opticrom Medical Vision S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.764 | 7.942 | 10.357 | 10.167 | 9.970 | 9.781 | 9.565 | 9.594 | 9.565 | 9.512 |
| Current Assets | 4.215 | 15.920 | 8.307 | 10.042 | 12.843 | 13.036 | 16.760 | 14.739 | 19.168 | 22.689 |
| Inventories | 2.497 | 1.600 | 919 | 6.992 | 9.278 | 9.251 | 9.376 | 13.383 | 15.770 | 13.645 |
| Receivables | 0 | 0 | 296 | 668 | 2.758 | 2.703 | 5.269 | 922 | 3.332 | 8.694 |
| Cash | 1.718 | 14.320 | 7.092 | 2.382 | 806 | 1.082 | 2.114 | 433 | 67 | 350 |
| Shareholders Funds | 1.612 | 11.704 | 17.500 | 17.838 | 19.151 | 19.113 | 23.688 | 19.116 | 19.850 | 19.138 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.367 | 12.159 | 1.164 | 2.372 | 3.662 | 3.704 | 2.637 | 5.216 | 8.883 | 13.063 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Opticrom Medical Vision S.r.l.